Showing 21 - 38 results of 38 for search '"Journal of Cancer Research and Practice"', query time: 0.06s Refine Results
  1. 21
    Durable Clinical Benefit after Dual Checkpoint Inhibition and Single-agent Nivolumab Following Pembrolizumab Failure in Mismatch Repair-deficient Colon Cancer

    Durable Clinical Benefit after Dual Checkpoint Inhibition and Single-agent Nivolumab Following Pembrolizumab Failure in Mismatch Repair-deficient Colon Cancer by Yat-Fung Chow, Hou-Hsuan Cheng, Ming-Huang Chen

    Published 2023-10-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 22
    Awardee Summary of 2023 Taiwan Oncology Society Clinical Research Award Recipient: Persistent Endeavors on Research of Digestive Cancers for Three Decades

    Awardee Summary of 2023 Taiwan Oncology Society Clinical Research Award Recipient: Persistent Endeavors on Research of Digestive Cancers for Three Decades by Kun-Huei Yeh

    Published 2024-01-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 23
    Pneumothorax during Alectinib Treatment for a Uterine Inflammatory Myofibroblastic Tumor with Lung Metastasis

    Pneumothorax during Alectinib Treatment for a Uterine Inflammatory Myofibroblastic Tumor with Lung Metastasis by Chang-Ting Lin, Chen-Hsuan Wu, Hsuan-Ying Huang, Chien-Ting Liu

    Published 2023-04-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 24
    Idiopathic Multicentric Castleman Disease following SARS-CoV-2 Vaccination

    Idiopathic Multicentric Castleman Disease following SARS-CoV-2 Vaccination by Chien-Yu Ker, Hung-Wei Liu, Yu-Chieh Su, Pang-Yu Lai*

    Published 2023-07-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 25
    Combination of Anti-programmed Cell Death Protein 1 and Antiangiogenesis Displaying a Response Disparity between Pulmonary and Nonpulmonary Metastases

    Combination of Anti-programmed Cell Death Protein 1 and Antiangiogenesis Displaying a Response Disparity between Pulmonary and Nonpulmonary Metastases by Bing-Syuan Chung, Peng-Chan Lin, Shang-Hung Chen, Yu-Min Yeh

    Published 2023-10-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 26
    5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan as a Potential Standard for Second-line Therapy in Extrapulmonary Neuroendocrine Carcinomas

    5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan as a Potential Standard for Second-line Therapy in Extrapulmonary Neuroendocrine Carcinomas by I-Wei Ho, Nai-Jung Chiang, Jiun-I Lai, Peter Mu-Hsin Chang, San-Chi Chen, Yi-Ping Hung, Ming-Huang Chen

    Published 2024-12-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 27
    Adjuvant Chemotherapy in Patients with Low-Risk Epithelial Ovarian Cancer: A Taiwanese Cohort Study

    Adjuvant Chemotherapy in Patients with Low-Risk Epithelial Ovarian Cancer: A Taiwanese Cohort Study by Yuan-Ting C. Lo, Hsiu-Ying Ku, Cheng-Shyong Chang, Hui-Ju Ch’ang, Chih-Ming Ho, Tsang-Wu Liu, Shih-Min Lin

    Published 2023-04-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 28
    TAFRO Syndrome Mimicking Solid Cancer and Successfully Treated by Tocilizumab: A Case and Literature Review

    TAFRO Syndrome Mimicking Solid Cancer and Successfully Treated by Tocilizumab: A Case and Literature Review by Pei-An Fu, Chia-Chi Wu, Ya-Ting Hsu

    Published 2023-10-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 29
    Primary Pancreatic Hepatoid Carcinoma: A Case Report and Literature Review

    Primary Pancreatic Hepatoid Carcinoma: A Case Report and Literature Review by Tyng-Wei Yang, Hsiang-Fong Kao*

    Published 2023-07-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 30
    Promising Remission with Reduced Bevacizumab and Pembrolizumab Dosage in a Patient with AT-rich Interaction Domain 1A Mutated Ovarian Clear-cell Carcinoma Refractory to Chemotherapy

    Promising Remission with Reduced Bevacizumab and Pembrolizumab Dosage in a Patient with AT-rich Interaction Domain 1A Mutated Ovarian Clear-cell Carcinoma Refractory to Chemotherap... by Cheng-Wei Huang, Ruo-Han Tseng

    Published 2024-01-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 31
    Left Kidney Undifferentiated Spindle Cell Sarcoma with Myeloid Cell Leukemia-1 Amplification: Therapeutic Response to Bortezomib, Venetoclax, and Dexamethasone Therapy

    Left Kidney Undifferentiated Spindle Cell Sarcoma with Myeloid Cell Leukemia-1 Amplification: Therapeutic Response to Bortezomib, Venetoclax, and Dexamethasone Therapy by Cheng-Yu Tang, Chueh-Chuan Yen

    Published 2023-10-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 32
    Significance of Baseline and Changes of Tumor Markers and Neutrophil-to-Lymphocyte Ratio in Predicting Overall Survival for Patients with Advanced Pancreatic Adenocarcinoma: A Retrospective Analysis

    Significance of Baseline and Changes of Tumor Markers and Neutrophil-to-Lymphocyte Ratio in Predicting Overall Survival for Patients with Advanced Pancreatic Adenocarcinoma: A Retr... by Makoto Kadokura, Keisuke Tanaka, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Nobuyuki Enomoto

    Published 2023-04-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 33
    Unfavorable Tumor Responses to Immunotherapy in the Liver: Lessons Learned from Clinical and Preclinical Studies

    Unfavorable Tumor Responses to Immunotherapy in the Liver: Lessons Learned from Clinical and Preclinical Studies by Li-Chun Lu, Gen-Sheng Feng, Chih-Hung Hsu

    Published 2023-04-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 34
    Promising Response with PI3K Inhibitor for a Patient with Heavily Pretreated PIK3CA Mutation Head-and-Neck Cancer

    Promising Response with PI3K Inhibitor for a Patient with Heavily Pretreated PIK3CA Mutation Head-and-Neck Cancer by Ming-Jing Lee, Hsiang-Fong Kao

    Published 2023-04-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 35
    An Anaplastic Lymphoma Kinase-positive Inflammatory Myofibroblastic Tumor with Rapidly Acquired Resistance to First-line Anaplastic Lymphoma Kinase Inhibitor: A Case and Literature Review

    An Anaplastic Lymphoma Kinase-positive Inflammatory Myofibroblastic Tumor with Rapidly Acquired Resistance to First-line Anaplastic Lymphoma Kinase Inhibitor: A Case and Literature... by Shu-Cheng Wu, Hsing-Wu Chen

    Published 2024-01-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 36
    Recurrent Diffuse Large B-Cell Lymphoma with the Initial Manifestation of Retinal Involvement

    Recurrent Diffuse Large B-Cell Lymphoma with the Initial Manifestation of Retinal Involvement by Wan-Ting Yeh, Jen-Tsun Lin*

    Published 2023-07-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 37
    David Slays Goliath: Exceptional Efficacy of Oral Vinorelbine in Conquering Metastatic Finger Angiosarcoma

    David Slays Goliath: Exceptional Efficacy of Oral Vinorelbine in Conquering Metastatic Finger Angiosarcoma by Te-Lin Hsu, San-Chi Chen

    Published 2024-01-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 38
    Comparing Cisplatin Dosing Schedules in Concurrent Chemoradiotherapy for Locally Advanced Head-and-Neck Cancer: A Comprehensive Review of Weekly Versus 3-Weekly Regimens

    Comparing Cisplatin Dosing Schedules in Concurrent Chemoradiotherapy for Locally Advanced Head-and-Neck Cancer: A Comprehensive Review of Weekly Versus 3-Weekly Regimens by Oscar Chi-Yu Yang, Nai-Wen Su, Yi-Shing Leu, Yi-Fang Chang

    Published 2024-12-01
    “…Journal of Cancer Research and Practice…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: